Trademark applications and grants for Oncolys Biopharma Inc. Oncolys Biopharma Inc has 8 trademark applications. The latest application filed is for "TELOMELYSIN"
Patent Application | Date |
---|---|
METHOD FOR ADMINISTERING ONCOLYTIC VIRUS TO TUMOR TISSUE, AND DEVICE FOR ADMINISTRATION 20220249127 - 17/610925 URATA; Yasuo ;   et al. | 2022-08-11 |
ANTI-CANCER-ASSOCIATED NON-TUMOR CELL AGENT COMPRISING VIRUS 20210393715 - 17/352576 FUJIWARA; Toshiyoshi ;   et al. | 2021-12-23 |
MOLECULARLY TARGETED COMBINATION DRUG FOR TUMOR TREATMENT AND PREVENTION 20150352076 - 14/763049 Sakai; Toshiyuki | 2015-12-10 |
DR5 gene promoter and SIAH-1 gene promoter 20110117644 - 12/385863 Sakai; Toshiyuki | 2011-05-19 |
Telomelysin/GFP-expressing recombinant virus 20110111480 - 12/895120 FUJIWARA; TOSHIYOSHI ;   et al. | 2011-05-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.